Kite Pharma (KITE) Tops Q3 EPS by 26c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
No Surpises in Kite Pharma (KITE) Q3, Mizuho Says; Positive Ahead of ASH
November 13, 2015 7:36 AM ESTMizuho Securities analyst Eric Criscuolo reiterated a Buy rating and $90 price target on Kite Pharma (NASDAQ: KITE) following Q3 results and with ASH approaching.
Criscuolo commented, "There were no major updates in KITE's 3Q earnings. We reiterate our Buy rating with the ASH... More



